 Barclays chief executive will undergo cancer treatment, the FTSE 100-listed lender said today. CS Venkatakrishnan, who will be treated for non-hodgkin lymphoma, said in a letter to colleagues that doctors have advised that my prognosis is excellent, and my condition is curable with their prescribed regimen. 